Barclays plans callable contingent coupon notes on biotech, tech ETFs

By Marisa Wong

Morgantown, W.Va., Feb. 8 – Barclays Bank plc plans to price callable contingent coupon notes due Feb. 18, 2022 linked to the lesser performing of the SPDR S&P Biotech exchange-traded fund and the Technology Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes pay a semiannual contingent coupon at an annualized rate of 13.1% if each underlier closes at or above its coupon barrier level, 70% of its initial level, on the related semiannual observation date.

The notes will be callable at par on any contingent coupon payment date.

The payout at maturity will be par unless the lesser-performing underlier finishes below its barrier level, 70% of its initial level, in which case investors will lose 1% for every 1% that the lesser-performing underlier declines from its initial level.

Barclays is the agent.

The notes will price Feb. 15.

The Cusip number is 06741WES5.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.